Quarterly report [Sections 13 or 15(d)]

Commitments and Contingencies - Additional Information (Details)

v3.25.1
Commitments and Contingencies - Additional Information (Details)
3 Months Ended
Mar. 31, 2025
USD ($)
Commitments and Contingencies [Line Items]  
Terms agreement description Under the August 2023 work orders, Minaris Advanced Therapies converted the Company’s non-dedicated suite to a dedicated suite for GMP manufacturing for the Company’s rese-cel and MuSK-CAART programs, or the Dedicated Suite, for an initial term of 18 months with two 18-month extensions at the Company’s sole option on six months' notice prior to the end of the term. In August 2024, the Company sent a notice to Minaris Advanced Therapies to extend the initial term of the Minaris Advanced Therapies Agreement by 18 months through August 2026
Rese-Cel and MuSK-CAART [Member]  
Commitments and Contingencies [Line Items]  
Early termination fee $ 1,080
Wuxi Agreement  
Commitments and Contingencies [Line Items]  
Early termination fee $ 1,500
Lease expiration month 18 months
Lonza Agreement [Member]  
Commitments and Contingencies [Line Items]  
Payment Of Obligation Term 12 months